Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

SHE:300452 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	176.44	176.55	119.42	161.54	130.71	89.25
Depreciation & Amortization	53.34	53.34	50.75	38.78	36.06	34.68
Other Amortization	1.08	1.08	0.42	0.28	0.13	-
Loss (Gain) From Sale of Assets	0.96	0.96	-0.11	0.01	0.27	0.12
Asset Writedown & Restructuring Costs	0.14	0.14	39.13	1.02	0.01	8.97
Loss (Gain) From Sale of Investments	-19.36	-19.36	-16.25	-19.05	-5.11	-7.83
Provision & Write-off of Bad Debts	-	-	-	0.05	-0.04	-0.01
Other Operating Activities	31.93	10.94	11.96	7.04	-1.13	-2.23
Change in Accounts Receivable	-53.12	-53.12	-96.59	-42.25	-98.58	-28.04
Change in Inventory	-3.56	-3.56	5.34	-2.91	-13.43	-28.91
Change in Accounts Payable	30.91	30.91	-3.27	-15.12	77.63	36.86
Change in Other Net Operating Assets	0.28	0.28	0.07	0.26	0.9	3.84
Operating Cash Flow	212.87	191.99	118.33	132.3	132.82	103.82
Operating Cash Flow Growth	74.27%	62.25%	-10.56%	-0.39%	27.93%	21.36%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-43.61	-40.73	-27.94	-54.92	-67.31	-31.47
Sale of Property, Plant & Equipment	0.14	0.47	0.55	0.1	0.69	0.55
Investment in Securities	-80	-	-7	-288.69	-29.31	5
Other Investing Activities	15.46	13.44	19.38	10.54	7.73	6.08
Investing Cash Flow	-108.01	-26.82	-15.01	-332.98	-88.21	-19.84

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Short-Term Debt Issued	-	3.46	14.85	338.88	49.8	31.15
Long-Term Debt Issued	-	15.02	32.22	-	-	-
Total Debt Issued	17.47	18.48	47.08	338.88	49.8	31.15
Short-Term Debt Repaid	-	-	-	-49.57	-41	-40.1
Long-Term Debt Repaid	-	-16.24	-50.52	-	-	-
Total Debt Repaid	-9.01	-16.24	-50.52	-49.57	-41	-40.1
Net Debt Issued (Repaid)	8.46	2.24	-3.44	289.31	8.8	-8.95
Repurchase of Common Stock	-	-	-22.51	-	-	-
Common Dividends Paid	-71.41	-71.43	-59.01	-59.78	-55.33	-46.32
Other Financing Activities	-	-	-0.25	-1.36	-1.99	-
Financing Cash Flow	-62.95	-69.19	-85.21	228.17	-48.52	-55.27

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Foreign Exchange Rate Adjustments	-1.95	-0.57	1.22	-0.01	2.56	-0.28
Net Cash Flow	39.97	95.4	19.33	27.47	-1.35	28.43

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	169.27	151.26	90.39	77.38	65.5	72.35
Free Cash Flow Growth	87.63%	67.34%	16.82%	18.13%	-9.46%	12.71%
Free Cash Flow Margin	17.70%	16.04%	10.24%	9.22%	9.30%	11.73%
Free Cash Flow Per Share	0.70	0.63	0.39	0.32	0.28	0.31
Levered Free Cash Flow	164.69	153.12	25.89	53.49	114.88	45.79
Unlevered Free Cash Flow	173.04	161.33	33.85	56.18	115.64	46.54

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Income Tax Paid	64.41	59.57	58.72	15.47	40.46	40.42
Change in Working Capital	-31.66	-31.66	-86.99	-57.37	-28.09	-19.13

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error